Blood pressure control and acceptability of Perindopril and its fixed dose combinations with Amlodipine or Indapamide, in younger patients with hypertension-Reference-Cited by-同舟云学术

Blood pressure control and acceptability of Perindopril and its fixed dose combinations with Amlodipine or Indapamide, in younger patients with hypertension

Published:2014-11 Issue:6 Volume:66 Page:635-639
ISSN:0019-4832
Container-title:Indian Heart Journal
language:en
Short-container-title:Indian Heart Journal

Author:

Bansal Sandeep,Chauhan D.K.,Ramesh D.,Barmare Shahid,Chakraborty Shaibal

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference9 articles.

1. Effects of different blood pressure lowering regimens on major cardiovascular events: results of prospectively designed overviews of randomised trials;Lancet,2003

2. Antihypertensive drug therapy: effects on stroke and coronary heart disease;Collins,1994

3. NICE Guidelines,2011

4. Prevalence, awareness and control of hypertension in Chennai – The Chennai Urban Rural Epidemiology Study;Mohan;JAPI,2007

5. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial;Hansson;Lancet,1998

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of perindopril/amlodipine fixed-dose combination in the treatment of hypertension: a systematic review;Frontiers in Pharmacology;2024-02-08

2. Management of Hypertension in the Asia-Pacific Region: A Structured Review;American Journal of Cardiovascular Drugs;2024-02-08

3. Pathophysiology of cough with angiotensin-converting enzyme inhibitors: How to explain within-class differences?;European Journal of Internal Medicine;2023-04

4. Method development for simultaneous estimation of Amlodipine Besylate and Perindopril Tertbutyl amine in fixed-dose;Heliyon;2023-03

5. Single-pill fixed-dose drug combinations to reduce blood pressure: the right pill for the right patient;Therapeutic Advances in Chronic Disease;2022-01